Pfizer, Unilab Prepare For Battle Over Lipitor Patent In The Philippines

SHANGHAI - After patent infringement disputes between Pfizer and Philippines-based generic drug manufacturer United Laboratories (Unilab) over Pfizer's Lipitor patent, a Makati court is expected to decide in January whether Unilab can continue selling its version of Pfizer's anti-cholesterol statin branded as Avamax. The two companies start presenting evidence this month